Search Results - "Kurashiki, Tomohiro"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Can Tolvaptan Protect Renal Function in the Early Postoperative Period of Cardiac Surgery? ― Results of a Single-Center Randomized Controlled Study by Kishimoto, Yuichiro, Nakamura, Yoshinobu, Harada, Shingo, Onohara, Takeshi, Kishimoto, Satoru, Kurashiki, Tomohiro, Fujiwara, Yoshikazu, Nishimura, Motonobu

    Published in Circulation Journal (2018)
    “…Background:Oral administration of tolvaptan, a vasopressin V2receptor antagonist, significantly reduces deterioration of renal function, which has recently…”
    Get full text
    Journal Article
  2. 2

    Molecular Pharmacological Approaches for Treating Abdominal Aortic Aneurysm by Miyake, Takashi, Miyake, Tetsuo, Kurashiki, Tomohiro, Morishita, Ryuichi

    Published in Annals of Vascular Diseases (25-06-2019)
    “…Abdominal aortic aneurysm (AAA) is considered to be a potent life-threatening disorder in elderly individuals. Although many patients with a small AAA are…”
    Get full text
    Journal Article
  3. 3

    Debranching thoracic endovascular aortic repair for distal aortic arch aneurysm in elderly patients aged over 75 years old by Shiraya, Suguru, Nakamura, Yoshinobu, Harada, Shingo, Kishimoto, Yuichiro, Onohara, Takeshi, Otsuki, Yuki, Kurashiki, Tomohiro, Horie, Hiromu, Nishimura, Motonobu

    Published in Journal of cardiothoracic surgery (10-01-2020)
    “…We examined the outcome of debranching thoracic endovascular aortic repair (d-TEVAR) without sternotomy for distal aortic arch aneurysm in patients aged ≥75…”
    Get full text
    Journal Article
  4. 4

    Prevention of Progression of Aortic Aneurysm by Peptide Vaccine Against Ang II (Angiotensin II) in a Rat Model by Kurashiki, Tomohiro, Miyake, Takashi, Nakagami, Hironori, Nishimura, Motonobu, Morishita, Ryuichi

    Published in Hypertension (Dallas, Tex. 1979) (01-12-2020)
    “…There is no proven medical therapy to inhibit the progression of abdominal aortic aneurysm (AAA) in the clinical setting. To develop a novel therapeutic…”
    Get full text
    Journal Article
  5. 5

    Molecular Pharmacological Approaches for Treating Abdominal Aortic Aneurysm by Miyake, Takashi, Miyake, Tetsuo, Kurashiki, Tomohiro, Morishita, Ryuichi

    Published in Annals of Vascular Diseases (2019)
    “…Abdominal aortic aneurysm (AAA) is considered to be a potent life-threatening disorder in elderly individuals. Although many patients with a small AAA are…”
    Get full text
    Journal Article
  6. 6

    Abstract 10772: Could Tolvaptan Protect Renal Function in the Early Postoperative Period After Cardiac Surgery? by Kishimoto, Yuichiro, Nakamura, Yoshinobu, Harada, Shingo, Ohnohara, Takeshi, Horie, Hiromu, Kurashiki, Tomohiro, Kishimoto, Satoru, Shiraya, Suguru, Saiki, Munehiro, Nishimura, Motonobu

    Published in Circulation (New York, N.Y.) (10-11-2015)
    “…IntroductionTolvaptan (TV), a vasopressin V2 inhibitor, has a strong diuretic effect, which is beneficial for body fluid management in patients with acute…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Abstract 12741: Prevention of Aneurysm Progression by a Peptide Vaccine Against Angiotensin II in a Rat Model by Kurashiki, Tomohiro, Miyake, Takashi, Nakagami, Hironori, Nishimura, Motonobu, Morishita, Ryuichi

    Published in Circulation (New York, N.Y.) (19-11-2019)
    “…Abdominal aortic aneurysm (AAA) is a common degenerative condition with high mortality in elderly individuals. However, there is no proven medical therapy to…”
    Get full text
    Journal Article
  9. 9

    Abstract 18414: Could Tolvaptan Prevent the New Onset of Atrial Fibrillation After Cardiac Surgery? by Kishimoto, Yuichiro, Nakamura, Yoshinobu, Fujiwara, Yoshikazu, Harada, Shingo, Ohnohara, Takeshi, Kishimoto, Satoru, Kurashiki, Tomohiro, Nishimura, Motonobu

    Published in Circulation (New York, N.Y.) (11-11-2016)
    “…IntroductionAtrial fibrillation (Af) occurs frequently after cardiac surgery and not only prolongs hospitalization but also influences the prognosis. Tolvaptan…”
    Get full text
    Journal Article